登录    
  
首页 > 期刊论文 > 论文摘要
局部晚期结肠癌术前化疗的研究进展
         
Advance in preoperative chemotherapy for locally advanced colon cancer

摘    要
局部晚期结肠癌患者手术后复发率高,预后较差,亟待提高患者的生存质量。研究表明,更早的全身治疗可有效根除肿瘤微转移,降低肿瘤复发和转移风险。术前化疗作为全身治疗的一种,在胃癌、乳腺癌及食管癌的治疗中被证明有效,但术前化疗在局部晚期结肠癌中的疗效尚不明确。为探索术前化疗在局部晚期结肠癌中的可行性及有效性,探讨局部晚期结肠癌的治疗策略,本综述重点探讨局部晚期结肠癌患者实施术前化疗的理论基础及临床疗效、CT作为一种有效手段用于筛选符合术前化疗标准的患者并评价术前化疗的疗效,以及结肠癌术前化疗未来研究的方向。
标    签 结肠肿瘤   药物疗法   预后   体层摄影术,螺旋计算机   Colonic neoplasms   Drug therapy   Prognosis   Tomography, spiral computed  
 
Abstract
The patients with locally advanced colon cancer have high recurrence rate and poor prognosis after operation, so their quality of life needs to be improved. The present studies show that the early systemic treatment is able to eradicate tumor micrometastasis effectively and reduce the risks of tumor recurrence and metastasis. Preoperative chemotherapy as a kind of systemic treatment is effective for gastric cancer, breast cancer and esophageal cancer, but its curative effect on locally advanced colon cancer is not clear. To explore the feasibility and effectiveness of preoperative chemotherapy for the locally advanced colon cancer and to discuss the treatment strategy of locally advanced colon cancer, this review focuses on the theoretical basis and the clinical efficacy of preoperative chemotherapy for the patients with locally advanced colon cancer, and CT as a mean of screening the patients with preoperative chemotherapy standards and evaluating the curative effect of preoperative chemotherapy, as well as the future research directions of preoperative chemotherapy for colon cancer.

中图分类号 R735.35   DOI 10.3781/j.issn.1000-7431.2018.55.065

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 综述

基金项目 河北省科技计划项目(编号:14277710D)

收稿日期 2018/1/22

修改稿日期 2018/3/7

网络出版日期

作者单位点击查看


引用该论文: WANG Guanglin,MENG Zesong,WANG Feifei,WANG Guiying. Advance in preoperative chemotherapy for locally advanced colon cancer[J]. Tumor, 2018, 38(7): 716~721
王光林,孟泽松,王飞飞,王贵英. 局部晚期结肠癌术前化疗的研究进展[J]. 肿瘤, 2018, 38(7): 716~721


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1):11-30.
 
【2】TORRE A, BRAY F, SIEGEL RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
 
【3】MOUTINHO C, MARTINEZ-CARDUS A, SANTOS C, et al. Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer[J]. J Natl Cancer Inst, 2014. 106(1):djt322.
 
【4】JEON Y, KIM TH, YOUN HJ, et al. A multicenter phaseⅡ trial of neoadjuvant chemotherapy with docetaxel and gemcitabine in locally advanced breast cancer[J]. J Breast Cancer, 2017, 20(4):340-346.
 
【5】TSUBURAYA A, NAGATA N, CHO H, et al. PhaseⅡ trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer[J]. Cancer Chemother Pharmacol, 2013, 71(5):1309-1314.
 
【6】LORUSSO D, RAMONDINO S, Mancini M, et al. PhaseⅡ trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma[J]. Int J Gynecol Cancer, 2014, 24(4):729-734.
 
【7】NORDLINGER B, SORBYE H, GLIMELIUS B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial[J]. Lancet, 2008, 371(9617):1007-1016.
 
【8】XU, Q, XU Y, SUN H, et al. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer[J]. J Magn Reson Imaging, 2018, 48(1):248-258.
 
【9】HASEGAWA S, GOTO S, MATSUMOTO T, et al. A Multicenter phase 2 study on the feasibility and efficacy of neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer[J]. Ann Surg Oncol, 2017, 24(12):3587-3595.
 
【10】ZHOU H, SONG Y, JIANG J, et al. A pilot phase Ⅱ study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer[J]. Chin J Cancer Res, 2016. 28(6):598-605.
 
【11】CUKIER M, SMITH AJ, MILOT L, et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experience[J]. Eur J Surg Oncol, 2012, 38(8):677-682.
 
【12】吴卫东, 邢同海. 术前化疗后结直肠癌组织中Fas/FasL和survivin的表达[J]. 肿瘤, 2006, 26(1):85-87.
 
【13】ARREDONDO J, GONZALEZ I, BAIXAULI J, et al. Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy[J]. J Gastrointest Oncol, 2014, 5(2):104-111.
 
【14】DAM C, LUND-RASMUSSEN V, PLOEN J, et al. Computed tomography assessment of early response to neoadjuvant therapy in colon cancer. Dan Med J, 2015, 62(7): A5103.
 
【15】JAKOBSEN A, ANDERSEN F, FISCHER A, et al. Neoadjuvant chemotherapy in locally advanced colon cancer. A phaseⅡtrial[J]. Acta Oncol, 2015, 54(10):1747-1753.
 
【16】ARREDONDO J, BAIXAULI J, PASTOR C, et al. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery[J]. Clin Transl Oncol, 2017, 19(3):379-385.
 
【17】HUANG C, HUANG MY, MA CJ, et al. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer[J]. Radiat Oncol, 2017, 12(1):48.
 
【18】SUZUKI C, BLOMQVIST L, SUNDIN A, et al. The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy[J]. Ann Oncol, 2012, 23(4):948-954.
 
【19】ADAM R, PASCAL G, CASTAING D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?[J]. Ann Surg, 2004, 240(6):1052-1061.
 
【20】PIESSEVAUX H, BUYSE M, SCHLICHTING M, et al. Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximabp[J]. J Clin Oncol, 2013, 31(30):3764-3775.
 
【21】MODEST DP, LAUBENDER RP, STINTZING S, et al. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trial[J]. Acta Oncol, 2013, 52(5):956-962.
 
【22】BENOIST S, NORDLINGER B. Neoadjuvant treatment before resection of liver metastases[J]. Eur J Surg Oncol, 2007, 33(Suppl 2):S35-41.
 
【23】ARREDONDO J, MARTINEZ P, BAIXAULI J, et al. Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stageⅣ colon cancer[J]. J Gastrointest Oncol, 2014, 5(2):148-153.
 
【24】DEHAL A, GRAFF-BAKER AN, VUONG B, et al. Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer[J]. J Gastrointest Surg, 2018, 22(2):242-249.
 
【25】LIU F, YANG L, WU Y, et al. CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phaseⅡ trial[J]. Chin J Cancer Res, 2016, 28(6):589-597.
 
【26】WIEGERING A, KUNZ M, HUSSEIN M, et al. Diagnostic value of preoperative CT scan to stratify colon cancer for neoadjuvant therapy[J]. Int J Colorectal Dis, 2015, 30(8):1067-1073.
 
【27】NORGAARD A, DAM C, JAKOBSEN A, et al. Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan[J]. Scand J Gastroenterol, 2014, 49(2):202-208.
 
【28】SMITH NJ, BEES N, BARBACHANO Y, et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials[J]. Br J Cancer, 2007, 96(7):1030-1036.
 
【29】LEONARS GD, BRENNER B, KEMENY NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma[J]. J Clin Oncol, 2005, 23(9):2038-2048.
 
【30】VLEDDER MG, DE JONG MC, PAWLIK TM, et al. Disappearing colorectal liver metastases after chemotherapy: should we be concerned?[J]. J Gastrointest Surg, 2010, 14(11):1691-1700.
 
相关信息
   标题 相关频次
 CRISPR/Cas9基因编辑技术在肿瘤研究及治疗中的应用
 8
 34例卵巢透明细胞癌临床分析
 4
 MicroRNA在结直肠癌的诊断、预后和化疗中的作用
 4
 MIC分型评价成人急-性髓系白血病中的淋系抗原表达
 4
 单纯放疗和放化疗综合治疗弥漫内生型脑干胶质瘤的前瞻性研究
 4
 复发性卵巢癌的化放疗研究
 4
 甲磺酸伊马替尼治疗晚期胃肠间质瘤的疗效及预后因素
 4
 结直肠癌单纯性肺转移90例患者预后相关因素分析
 4
 深部热化疗对复发转移性结直肠癌患者生存的影响及预后相关因素
 4
 胃神经内分泌癌临床病理特征及预后相关因素
 4
 小细胞癌和鳞状细胞癌复合型肺癌术后化疗的意义
 4
 新藤黄酸诱导人结肠癌HCT116细胞凋亡的作用机制研究
 4
 预测淋巴结转移阴茎癌术后复发的分类及回归树分析
 4
 原发系统性间变性大细胞淋巴瘤45例临床分析
 4
 原发性扁桃体局限期弥漫性大B细胞淋巴瘤的临床病理特征及预后:对33例患者的分析
 4
 基因多态性预测结直肠癌化疗效果和不良反应
 3
 藤龙补中汤促人结肠癌RKO细胞衰老及其可能的作用机制
 3
 晚期卵巢上皮癌二次细胞减灭术的临床探讨
 3
 ART1基因沉默对小鼠结肠癌CT26细胞转移潜能的影响及作用机制的研究
 2
 c-myc反义寡核苷酸对表达FHIT基因的结肠癌细胞增殖及凋亡作用的影响
 2
 HOX11原癌基因的活化对儿童急性白血病预后的影响
 2
 MDR1基因表达与肝癌患者TACE治疗反应性及预后的关系
 2
 MTHFRABCG2单核苷酸多态性对晚期结直肠癌一线化疗疗效的预测作用
 2
 S100A4基因差异表达与结直肠癌分化、转移及预后的关系
 2
 TFPI-2基因表达变化与声门上喉癌侵袭转移及预后的相关性研究
 2
 XRCC1Arg399GIn多态性与进展期胃癌铂类药物化疗敏感性关系的Meta分析
 2
 125I内放疗联合热疗和化疗治疗中晚期肿瘤的临床观察
 2
 18F-FDG PET-CT及其他临床病理因素对套细胞淋巴瘤预后的预测价值
 2
 1~3个腋淋巴结阳性的T1~T2期乳腺癌改良根治术后患者预后因素分析
 2
 105例急性髓系白血病p170、GSTP-1表达分析
 2

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2